UNZ-99373-28138
3 vaccinations
3 coded responses
17 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 980 / WA
- Registered
- 2021-06-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-21
Dose 1 — Pfizer-BioNTech
-
2021-06-15
Registered in v-safe
-
2021-06-15
Dose 2 — Pfizer-BioNTech
- 2021-06-15
-
2021-06-16
Survey response — days 1–6 daily, dose 2MedDRA: Muscle spasms — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Leg crampsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-06-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-06-19
- 2021-06-20
- 2021-06-21
- 2021-06-22
- 2021-06-29
- 2021-07-06
- 2021-07-13
- 2021-07-20
-
2021-07-27
Survey response — day 42, dose 2MedDRA: Fatigue, Hypersensitivity, Nasopharyngitis, Oropharyngeal pain, Pre-existing disease, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Cold and allergy symptoms: fatigue, runny nose, sore throatMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-14
- 2021-12-14
-
2022-01-11
Dose 3 — Pfizer-BioNTech
- 2022-07-12
-
2023-01-11
Survey response — 12 months, dose 3MedDRA: COVID-19, Chills, Cough, Headache, Pain, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-21 | Pfizer-BioNTech | |
| 2 | 2021-06-15 | Pfizer-BioNTech | |
| 3 | 2022-01-11 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Leg cramps
Release 9 — day 42, dose 2
Symptoms: Cold and allergy symptoms: fatigue, runny nose, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypersensitivity | ✓ | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | ✓ | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release